<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Twenty children with various <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematological malignancies</z:e> (nine with <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo>, eight with <z:hpo ids='HP_0011009'>acute</z:hpo> non-lymphoblastic <z:hpo ids='HP_0001909'>leukemia</z:hpo>, two with <z:hpo ids='HP_0005506'>chronic myelogenous leukemia</z:hpo>, one with malignant <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and one with 7-<z:mp ids='MP_0004026'>monosomy</z:mp>) and four with severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> were treated with allogeneic or syngeneic bone marrow transplantation (BMT) between September 1977 and September 1988 </plain></SENT>
<SENT sid="1" pm="."><plain>Eleven patients are surviving currently and ten are disease free 8 to 51 months after BMT </plain></SENT>
<SENT sid="2" pm="."><plain>Conditioning regimen consisted of total body irradiation (TBI) and <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> in twenty patients </plain></SENT>
<SENT sid="3" pm="."><plain>Two patients did not receive TBI </plain></SENT>
<SENT sid="4" pm="."><plain>Graft failure was observed in five patients and complete recovery of recipient marrow was seen in two of them </plain></SENT>
<SENT sid="5" pm="."><plain>Eleven patients developed <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft-versus-host disease</z:e> (GvHD) with grade I-II in eight patients </plain></SENT>
<SENT sid="6" pm="."><plain>Three patients suffered from <z:hpo ids='HP_0011010'>chronic</z:hpo> GvHD </plain></SENT>
<SENT sid="7" pm="."><plain>Seven patients with <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> relapsed and <z:hpo ids='HP_0000001'>all</z:hpo> but one died of <z:hpo ids='HP_0001909'>leukemia</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>Early <z:hpo ids='HP_0011420'>death</z:hpo> occurred in two undergone BMT in poor clinical conditions </plain></SENT>
<SENT sid="9" pm="."><plain>Performance status in 100% in surviving patients except one </plain></SENT>
<SENT sid="10" pm="."><plain>Efforts to improve these results are that BMT should be considered early in the course of their disease for patients who are at risk for relapse with conventional chemotherapy and improved conditioning regimens to reduce <z:hpo ids='HP_0001909'>leukemia</z:hpo> relapse after BMT for patient with the second or subsequent remission </plain></SENT>
</text></document>